Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor ...

The complexities of tech transfer may be overcome by data-driven approaches, digital tools, and effective communication.

This approach supports our long-term objective of establishing Bionoid Pharma as a leader in AI-powered health solutions." The AI-driven platform at the heart of BINP's growth strategy will ...

Needham analyst Joseph Stringer has maintained their bullish stance on INZY stock, giving a Buy rating today. Joseph Stringer has given his ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...

The study indicated that pharma ads can have a practical impact on disease awareness and the care journey for patients.

Zealand Pharma AS (ZLDPF) showcases promising trial results and strategic partnerships while navigating high R&D expenses and ...

Remote patient monitoring platform Wanda announced a strategic partnership with the COPD Foundation. The Access Group is set ...

Analyst Keay Nakae from Chardan Capital maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) and keeping the price target ...

Catalyx and INEL have announced a strategic partnership aimed at delivering comprehensive packaging solutions for the pharmaceutical sector. This collaboration is set to enhance processes such as ...

AI-Driven Platform and Strategic Acquisitions to Drive Health & Wellness Growth and Profitability TORONTO, ON / ACCESSWIRE / November 5, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP ...

TORONTO, ON / ACCESSWIRE / November 5, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) has outlined a five-year roadmap focused on expanding revenue streams and brand presence through a targeted ...